152 related articles for article (PubMed ID: 37101747)
1. Integrated Analyses of the Expression and Prognostic Value of EPHB6 in Cervical Cancer and Its Correlation with Immune Infiltrates.
Xiang S; Wei M; Zhao L; Lin A; Xiong Z
J Oncol; 2023; 2023():2258906. PubMed ID: 37101747
[TBL] [Abstract][Full Text] [Related]
2. Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer.
Jia X; Zhang D; Zhou C; Yan Z; Jiang Z; Xie L; Jiang J
Front Oncol; 2023; 13():1175183. PubMed ID: 37637034
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of erythropoietin-producing hepatocyte B6 receptor tyrosine kinase in prostate cancer.
Mohamed ER; Noguchi M; Hamed AR; Eldahshoury MZ; Hammady AR; Salem EE; Itoh K
Oncol Lett; 2015 Apr; 9(4):1672-1676. PubMed ID: 25789021
[TBL] [Abstract][Full Text] [Related]
4. CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer.
Hu P; Lei L; Wang Y; Tian X; Wei X; Jiang N; Liu L
Mediators Inflamm; 2023; 2023():1075265. PubMed ID: 37057131
[TBL] [Abstract][Full Text] [Related]
5. Reduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor.
Liu J; Xu B; Xu G; Zhang X; Yang X; Wang J
Cancer Biomark; 2017 Jul; 19(3):241-248. PubMed ID: 28453458
[TBL] [Abstract][Full Text] [Related]
6. Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma.
Fan Z; Wu S; Sang H; Li Q; Cheng S; Zhu H
Mediators Inflamm; 2023; 2023():9162249. PubMed ID: 37035759
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma.
Zhang H; Yuan J; Xiang Y; Liu Y
J Oncol; 2022; 2022():2099327. PubMed ID: 36284635
[TBL] [Abstract][Full Text] [Related]
8. Structure of the EphB6 receptor ectodomain.
Mason EO; Goldgur Y; Robev D; Freywald A; Nikolov DB; Himanen JP
PLoS One; 2021; 16(3):e0247335. PubMed ID: 33770085
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the Immune-Related Long Noncoding RNA Prognostic Signature and Inflammatory Microenvironment for Cervical Cancer.
Yao H; Jiang X; Fu H; Yang Y; Jin Q; Zhang W; Cao W; Gao W; Wang S; Zhu Y; Ying J; Tian L; Chen G; Tong Z; Qi J; Zhou S
Front Pharmacol; 2022; 13():870221. PubMed ID: 35662687
[No Abstract] [Full Text] [Related]
10. A Novel HCC Prognosis Predictor EEF1E1 Is Related to Immune Infiltration and May Be Involved in EEF1E1/ATM/p53 Signaling.
Han R; Feng P; Pang J; Zou D; Li X; Geng C; Li L; Min J; Shi J
Front Oncol; 2021; 11():700972. PubMed ID: 34282404
[TBL] [Abstract][Full Text] [Related]
11. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.
Tang XX; Zhao H; Robinson ME; Cohen B; Cnaan A; London W; Cohn SL; Cheung NK; Brodeur GM; Evans AE; Ikegaki N
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10936-41. PubMed ID: 10984508
[TBL] [Abstract][Full Text] [Related]
12. Application of an Autophagy-Related Gene Prognostic Risk Model Based on TCGA Database in Cervical Cancer.
Shi H; Zhong F; Yi X; Shi Z; Ou F; Xu Z; Zuo Y
Front Genet; 2020; 11():616998. PubMed ID: 33633773
[No Abstract] [Full Text] [Related]
13. Expression of EphB6 in ovarian serous carcinoma is associated with grade, TNM stage and survival.
Gu Y; Li F; Qian N; Chen X; Wang H; Wang J
J Clin Pathol; 2016 May; 69(5):448-53. PubMed ID: 26468391
[TBL] [Abstract][Full Text] [Related]
14. High expression of EphB6 protein in tongue squamous cell carcinoma is associated with a poor outcome.
Dong Y; Pan J; Ni Y; Huang X; Chen X; Wang J
Int J Clin Exp Pathol; 2015; 8(9):11428-33. PubMed ID: 26617870
[TBL] [Abstract][Full Text] [Related]
15. A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia.
Colucci M; Trivieri N; Mencarelli G; De Santis E; Sansico F; Tamiro F; Visioli A; Barile C; Pracella R; Rossi G; Binda E; Giambra V
Biomark Res; 2023 Oct; 11(1):92. PubMed ID: 37858274
[TBL] [Abstract][Full Text] [Related]
16. Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.
Peng L; Tu P; Wang X; Shi S; Zhou X; Wang J
J Mol Histol; 2014 Oct; 45(5):555-63. PubMed ID: 24912672
[TBL] [Abstract][Full Text] [Related]
17. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.
Truitt L; Freywald T; DeCoteau J; Sharfe N; Freywald A
Cancer Res; 2010 Feb; 70(3):1141-53. PubMed ID: 20086179
[TBL] [Abstract][Full Text] [Related]
18. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
Wang Y; Zhang L; Wang B; Cheng Y
Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
[TBL] [Abstract][Full Text] [Related]
19. A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines.
Fox BP; Kandpal RP
Cancer Genomics Proteomics; 2011; 8(4):185-93. PubMed ID: 21737611
[TBL] [Abstract][Full Text] [Related]
20. DNA-based assay for EPHB6 expression in breast carcinoma cells as a potential diagnostic test for detecting tumor cells in circulation.
Fox BP; Kandpal RP
Cancer Genomics Proteomics; 2010; 7(1):9-16. PubMed ID: 20181626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
